| Issuer | % of Class | Filed |
|---|---|---|
|
Escalon Medical Corp.
13G/A
Amendment 2
ESMC · 296074305
|
0% |
10/6/2025
Event 10/6/2025
|
|
Escalon Medical Corp.
13G/A
Amendment 1
ESMC · 296074305
|
6.3% |
7/8/2025
Event 7/8/2025
|
|
Escalon Medical Corp.
13G
ESMC · 296074305
|
6.2% |
5/23/2025
Event 5/19/2025
|
|
Escalon Medical Corp.
13G
ESMC · 296074305
|
6.2% |
5/23/2025
Event 5/19/2025
|
|
Nuvve Holding Corp.
13G/A
Amendment 1
NVVE · 67079Y308
|
4.0% |
3/31/2025
Event 3/28/2025
|
|
Nuvve Holding Corp.
13G
NVVE · 67079Y308
|
9.4% |
3/28/2025
Event 3/28/2025
|
|
Nuvve Holding Corp.
13G
NVVE · 67079Y308
|
9.4% |
3/28/2025
Event 3/28/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.